Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Schroeder, Michael
add a person with the name Schroeder, Michael
 

Other publications of authors with the same name

A community effort in SARS‐CoV‐2 drug discovery, , , , , , , , , and 142 other author(s). Molecular Informatics, (November 2023)Netrank: network-based approach for biomarker discovery, , , , , , and . BMC bioinformatics, (Jul 29, 2023)Publisher Copyright: © 2023, The Author(s)..The BOD1L subunit of the mammalian SETD1A complex sustains the expression of DNA damage repair genes despite restraining H3K4 trimethylation, , , , , , , , , and 5 other author(s). (April 2023)PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA, , , , , , and . Nucleic Acids Res., 49 (W1): W530--W534 (July 2021)Word-based GWAS harnesses the rich potential of genomic data for E. coli quinolone resistance, , , and . Frontiers in microbiology, (2023)Copyright © 2023 Malekian, Sainath, Al-Fatlawi and Schroeder..A genome-wide scan of wastewater E. coli for genes under positive selection: focusing on mechanisms of antibiotic resistance, , , , and . Scientific Reports, (May 2022)Deep learning improves pancreatic cancer diagnosis using RNA-based variants, , , , , , , , , and 4 other author(s). Cancers (Basel), 13 (11): 2654 (May 2021)Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes, , , , , , and . European Journal of Nuclear Medicine and Molecular Imaging, 49 (4): 1176–1186 (October 2021)Is Protein BLAST a thing of the past?, , and . Nature communications, (Dec 11, 2023)Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor, , , , , and . Comput. Struct. Biotechnol. J., (June 2021)